Curbstone Financial Management Corp’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-7,600
| Closed | -$427K | – | 194 |
|
2024
Q4 | $427K | Sell |
7,600
-250
| -3% | -$14K | 0.09% | 180 |
|
2024
Q3 | $535K | Sell |
7,850
-7,980
| -50% | -$544K | 0.11% | 159 |
|
2024
Q2 | $669K | Buy |
15,830
+200
| +1% | +$8.45K | 0.15% | 132 |
|
2024
Q1 | $1.08M | Sell |
15,630
-650
| -4% | -$44.9K | 0.23% | 105 |
|
2023
Q4 | $1.2M | Buy |
16,280
+900
| +6% | +$66.6K | 0.27% | 88 |
|
2023
Q3 | $1.05M | Hold |
15,380
| – | – | 0.26% | 95 |
|
2023
Q2 | $1.44M | Buy |
15,380
+200
| +1% | +$18.8K | 0.34% | 78 |
|
2023
Q1 | $1.03M | Buy |
15,180
+1,250
| +9% | +$84.8K | 0.25% | 97 |
|
2022
Q4 | $690K | Sell |
13,930
-4,180
| -23% | -$207K | 0.17% | 127 |
|
2022
Q3 | $588K | Sell |
18,110
-2,450
| -12% | -$79.5K | 0.15% | 138 |
|
2022
Q2 | $810K | Sell |
20,560
-3,700
| -15% | -$146K | 0.19% | 120 |
|
2022
Q1 | $1.7M | Buy |
24,260
+390
| +2% | +$27.3K | 0.31% | 79 |
|
2021
Q4 | $1.86M | Hold |
23,870
| – | – | 0.33% | 77 |
|
2021
Q3 | $2.28M | Buy |
23,870
+650
| +3% | +$62K | 0.43% | 62 |
|
2021
Q2 | $2.89M | Buy |
23,220
+1,230
| +6% | +$153K | 0.54% | 52 |
|
2021
Q1 | $2.9M | Buy |
21,990
+810
| +4% | +$107K | 0.58% | 49 |
|
2020
Q4 | $2.81M | Sell |
21,180
-250
| -1% | -$33.1K | 0.59% | 49 |
|
2020
Q3 | $2.19M | Buy |
21,430
+280
| +1% | +$28.5K | 0.52% | 52 |
|
2020
Q2 | $1.84M | Buy |
21,150
+150
| +0.7% | +$13K | 0.48% | 55 |
|
2020
Q1 | $1.22M | Sell |
21,000
-470
| -2% | -$27.3K | 0.37% | 70 |
|
2019
Q4 | $1.99M | Buy |
+21,470
| New | +$1.99M | 0.47% | 54 |
|